InvestorsHub Logo
Followers 8
Posts 357
Boards Moderated 0
Alias Born 07/30/2015

Re: None

Thursday, 03/16/2017 9:04:47 PM

Thursday, March 16, 2017 9:04:47 PM

Post# of 9941
Questions regarding patents for their glaucoma and EB drugs. I've invested in a couple other cannabinoid companies and InMed is interesting as well. I've seen they've issued press releases that they filed provisional patents for both drug candidates in 2015 and then state again they are filing a provisional patent for EB again this year. What happened in 2015? Also, every biotech company I've researched provides patent numbers for their patents or provisional patents yet I can't find any patent numbers in InMed's regulatory filings. Can anyone shed light on this and if they've seen the patent or provisional numbers that would be issued?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News